Resultados de Búsqueda

NICE

NICE

Evidence on the safety and efficacy of laparoscopic renal denervation for loin pain haematuria syndrome is inadequate in quality and quantity. Therefore, this procedure should only be used in the context of research. Further research should report details of patient selection, technique used and long-term follow-up outcomes.

NICE

NICE

FFR or iFR can be used with invasive coronary angiography to assess coronary stenosis. However, they can have unpleasant side effects and increase the risk of adverse events, such as damage to the artery. CAAS vFFR and QAngio QFR use X‑ray images taken during an invasive coronary angiography to construct a 3D image of the artery. This image is used to estimate the effect of coronary stenosis on blood flow through the artery without the side effects and risk of adverse events of FFR or ...

NICE

NICE

Evidence on the safety of coronary sinus narrowing device implantation for refractory angina shows well-recognized complications. Evidence on efficacy is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. The procedure should only be done in specialist centres by interventional cardiologists with specific training in the technique.

NICE

NICE

Evidence on the safety and efficacy of percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure is adequate to support using this procedure provided that standard arrangements are in place for clinical governance, consent and audit. Patient selection, continuing monitoring and management should be done by a multidisciplinary team. This should include healthcare professionals (both a doctor and a nurse) experienced in managing chronic ...

Choosing Wisely Australia

The Thoracic Society of Australia and New Zealand

Sarcoidosis is a multisystemic disease with heterogenous clinical presentations. Diagnosis of sarcoidosis is often challenging because of the lack of reliable biomarkers and other gold standard tests. Unusually high serum angiotensin converting enzyme (ACE) is present in up to 75 percent of untreated patients. However, testing for high serum ACE level has been repeatedly demonstrated to have a poor sensitivity, insufficient specificity (including a false positive rate of around 10 percent) and ...